Skip to main content
. 2022 May 4;2(5):286–292. doi: 10.1158/2767-9764.CRC-22-0023

TABLE 1.

Cohort descriptions

VICC-1
Response
 No NAC 21
 pCR 9
 RD-nR 16
 RD-R 7
Receptor status
 TNBC 17
 HR+HER2+ 9
 HR+HER2 19
 HRHER2+ 8
GeparNuevo
Response
 RD 18
 pCR 23
TNBC
 Yes 41
 No 0
Instituto Valenciano
Metastasis
 Yes 5
 No 9
Hormone receptor +
 Yes 14
 No 0
VICC-SD
Response
 RD 75
 pCR 35
Receptor status
 TNBC 50
 HR+HER2+ 6
 HR+HER2 44
 HRHER2+ 10